Biotech Startups

Infinite Roots cultivates mycelium (mushroom roots) via liquid fermentation using natural side streams such as brewers' spent grain, turning it into protein-, fiber-, and vitamin-rich culinary ingredients. The company operates in the alternative protein and sustainable foodtech category, producing meat and food alternatives for consumer meals and dining.

4 investors

BETVIBE is an online gaming platform offering 3,000+ casino games and 50+ sports betting markets specifically designed for Indian players. The platform operates under Anjouan Gaming Commission licensing with INR payments, popular local payment methods, and aims to deliver fast withdrawal processing.

4 investors

4 investors

Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data. The company targets the development of treatments for challenging diseases through membrane-permeable and orally available compounds.

4 investors

InSilicoTrials provides a platform for clinical trial simulation and design optimization using mechanistic models, AI, and digital twins. The platform helps pharmaceutical companies, biotech firms, and regulators reduce development risk and accelerate the path from drug discovery to patient access.

4 investors

Instylla develops resorbable liquid embolic agents for interventional radiology and oncology, including the Embrace Hydrogel Embolic System and the Tembo Embolic System used to embolize hypervascular tumors and occlude peripheral blood vessels. Its products are used by physicians treating hypervascular tumors in the peripheral vasculature.

4 investors

4 investors

Biopharmaceutical company developing innovative therapies for chronic diseases using proprietary drug delivery systems.

4 investors

Intercept Pharmaceuticals is a biopharmaceutical company developing medicines for rare and serious liver diseases, with research centered on Farnesoid X Receptor (FXR) biology for conditions such as severe alcohol-associated hepatitis. Founded in 2002, it is a wholly owned subsidiary of Alfasigma.

4 investors

InventisBio (益方生物) is a biopharmaceutical company that develops small-molecule drugs, including candidates targeting KRAS G12C for lung and pancreatic cancer and treatments for moderate-to-severe plaque psoriasis. Based in Shanghai, China, it focuses on oncology and other therapeutic areas with a global outlook.

4 investors

Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.

4 investors

Invirsa is a clinical-stage biopharmaceutical company developing DNA damage response therapeutics, with lead compound INV-102 in development for ocular conditions including sulfur mustard gas injury and diabetic dry eye disease.

4 investors

Invivyd develops monoclonal antibody medicines for the prevention and treatment of serious viral infectious diseases, starting with COVID-19 and other high-need indications. It uses a proprietary integrated technology platform to design antibodies that are more potent and resistant to viral evolution.

4 investors

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.

4 investors

Isomorphic Labs applies artificial intelligence to drug discovery, working to develop treatments for serious diseases. It operates in the biotech and AI space.

4 investors

Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers. It serves patients with high unmet medical needs in rare disease and rare cancer areas.

4 investors

Jellatech uses cellular agriculture to produce functional, native collagen without animals. The company positions its process as a more sustainable alternative for producing high-quality collagen.

4 investors

Kaleidoscope provides a software platform for scientific R&D teams to track and communicate project data, manage complex research processes, and accelerate decision-making. The platform serves biotech and engineering teams seeking alternatives to fragmented spreadsheet-based workflows.

4 investors

Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies. It applies its integrated discovery platform to develop drugs for challenging diseases.

4 investors

Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases. The company is a clinical-stage biotech firm focused on next-generation gene correction.

4 investors

Kascaid is developing a wearable biosensor platform that measures immune biomarkers from interstitial fluid on demand, capturing immune activity through the skin. The technology targets clinical trials, research, and patient care to enable continuous, low-burden immune monitoring.

4 investors

4 investors

Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity. Its pipeline of ADC candidates targets solid tumors and other cancer indications.

4 investors

4 investors